124 related articles for article (PubMed ID: 18504652)
1. The sensitivity of BRCA1 mutation carriers to ionising radiation: questions of methodology.
Chechlinska M; Nowak R
Breast Cancer Res Treat; 2009 May; 115(2):433. PubMed ID: 18504652
[No Abstract] [Full Text] [Related]
2. Early radiation exposures and BRCA1-associated breast cancer in young women from Poland.
Gronwald J; Pijpe A; Byrski T; Huzarski T; Stawicka M; Cybulski C; van Leeuwen F; Lubiński J; Narod SA
Breast Cancer Res Treat; 2008 Dec; 112(3):581-4. PubMed ID: 18205043
[TBL] [Abstract][Full Text] [Related]
3. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
4. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
James PA; Harris M; Lindeman GJ; Mitchell G
J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
[No Abstract] [Full Text] [Related]
5. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
Chlebowski RT; Prentice RL
J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
[No Abstract] [Full Text] [Related]
6. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Eisinger F; Huiart L
J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
[No Abstract] [Full Text] [Related]
7. Can genetic testing guide treatment in breast cancer?
Tutt A; Ashworth A
Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in asymptomatic BRCA1/2 mutation carriers.
Dagan E; Shochat T
Prev Med; 2009 Feb; 48(2):193-6. PubMed ID: 19084553
[TBL] [Abstract][Full Text] [Related]
9. Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania.
Janavicius R; Pepalyte I; Kucinskas V
Breast Cancer Res Treat; 2009 Sep; 117(2):467-9. PubMed ID: 18763032
[No Abstract] [Full Text] [Related]
10. Update on genetic predisposition to breast cancer.
Ahmed M; Lalloo F; Evans DG
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
[TBL] [Abstract][Full Text] [Related]
11. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
12. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
Fuller S; Liebens F; Carly B; Pastijn A; Rozenberg S
Breast J; 2008; 14(6):603-4. PubMed ID: 19054005
[No Abstract] [Full Text] [Related]
14. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
Meng J; Shi YR; Niu RF; Fu L
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Matloff ET; Barnett RE; Bober SL
Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer: genetic predisposition and exposure to radiation.
Bennett LM
Mol Carcinog; 1999 Nov; 26(3):143-9. PubMed ID: 10559788
[TBL] [Abstract][Full Text] [Related]
17. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
18. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
[TBL] [Abstract][Full Text] [Related]
19. Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer.
Hashemian AH; Hajizadeh E; Kazemnejad A; Atri M; Mehdipour P
Saudi Med J; 2009 Jan; 30(1):41-4. PubMed ID: 19139771
[TBL] [Abstract][Full Text] [Related]
20. Hereditary breast cancer: from bench to bedside.
De Grève J; Sermijn E; De Brakeleer S; Ren Z; Teugels E
Curr Opin Oncol; 2008 Nov; 20(6):605-13. PubMed ID: 18841041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
